Total market for genitourinary drugs to grow to $30.7 billion in 2016

The total market for genitourinary drugs is projected to increase from $26.5 billion in 2011 to $30.7 billion in 2016 at a compound annual growth rate (CAGR) of 3% for a period of five years, from 2011 to 2016.
Learn about the specific classes of genitourinary diseases and the pharmaceutical products for their treatment, and learn about the emerging players, strategies for accessing emerging markets, specific disease prevalence and geographies in order to allocate resources and make effective decisions…
Use this report to:

• Gain an overview of leading and emerging drug products for each genitourinary disease
• Learn about the genitourinary disease drug market accompanied by product, company,geography and mechanism of action by geographic region or country
• Explore information from detailed product analyses within health and wellness subsegments to overall industry trends
• Quantify and qualify the market for drug products to treat various genitourinary diseases in both men and women.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Pharmaceuticals

SUMMARY FIGURE

MAJOR GENITOURINARY DRUG CATEGORIES REVENUE, 2009-2016
($ MILLIONS)*

Source: BCC Research